Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The funder had no role in the design, data collection, data analysis, and reporting of this study
Here is a great thread we found from Layne Norton, a guy we interviewed over ten years ago whose interview is still well worth a read
This is the rationale behind its FDA-approved use
To date, the side effect profile looks manageable, and no unexpected major safety issues have been revealed in Phase 2 clinical trials
US$ 26.91
US$ 22.38
)
US$ 21.08
